BANK OF AMERICA CORP /DE/
BankPosition in HRTX — Heron Therapeutics, Inc. /De/
CIK 70858
CHARLOTTE, NC
Position in HRTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$46,598
-$82,185 QoQ
Shares Held
108,369
-32.7% QoQ
Ownership
0.057%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#56
of 160 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,050,306,032 across 338 Biotechnology names. HRTX ranks #323 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in HRTX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $46,598 | 108,369 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $128,783 | 160,979 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $174,777 | 134,445 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $922,409 | 732,073 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $2,225,806 | 1,075,269 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,129,689 | 968,041 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $1,601,587 | 1,046,790 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,902,296 | 955,928 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,520,046 | 434,299 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $651,065 | 235,042 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $317,011 | 186,478 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $94,537 | 91,784 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $70,281 | 60,589 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $160,070 | 106,007 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $288,989 | 115,596 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $2,392,131 | 566,856 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,028,153 | 726,937 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $9,191,146 | 1,606,844 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $3,152,075 | 345,244 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $1,138,868 | 106,536 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,910,029 | 123,069 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $4,699,357 | 289,905 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $4,269,267 | 201,666 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $3,352,133 | 226,190 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $3,140,715 | 213,509 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $4,245,850 | 361,657 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||